The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. This year’s metric has recorded a Price decrease of -37.75%. However, over the past six months, we’ve seen a weaker performance of 30.93%. The price of TNXP fallen by 71.80% over the last 30 days. And in the last five days, it has surged by 50.62%.
Tonix Pharmaceuticals Holding Corp’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $1193.28 on 03/19/24, and the lowest price during that time was $6.76, recorded on 03/04/25.
52-week price history of TNXP Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Tonix Pharmaceuticals Holding Corp’s current trading price is -98.28% away from its 52-week high, while its distance from the 52-week low is 203.70%. The stock’s price range over this timeframe has been between $6.76 and $1193.28. The shares of the Healthcare sector company recorded a trading volume of approximately 2.55 million for the day, which was comparatively higher than the average daily volume of 1.63 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Tonix Pharmaceuticals Holding Corp (TNXP) has experienced a quarterly decline of -10.31% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 114.77M and boasts a workforce of 103 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 21.10, with a change in price of +1.54. Similarly, Tonix Pharmaceuticals Holding Corp recorded 1,369,830 in trading volume during the last 100 days, posting a change of +8.11%.
TNXP’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for TNXP stands at 0.12. Similarly, the long-term debt-to-equity ratio is also 0.08.
TNXP Stock Stochastic Average
Tonix Pharmaceuticals Holding Corp’s raw stochastic average for the past 50 days is currently at 26.72%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 92.17%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 80.60% and 70.31%, respectively.
